ProShares Trust - ProShares Short S&P500 -1x Shares
SH
Get informed when a big investor buys or sells
+ FollowShare Statistics
| Market cap | $29.76 Billion |
|---|---|
| Enterprise Value | $29.59 Billion |
| Dividend Yield | $1.49 (4.47%) |
| Earnings per Share | $- |
| Beta | -0.96 |
| Outstanding Shares | - |
Return
| Return on Equity | -25.93% |
|---|---|
| Return on Assets | -23.92% |
| Return on Invested Capital | -27.36% |
Valuation & Multiples
| P/E Ratio | - |
|---|---|
| PEG | - |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 2265.7 |
| Enterprise Value to EBIT | -393.61 |
| Enterprise Value to Net Income | -420 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0.04 |
Revenue Sources
No data
Insider Trades
Institutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 3.5311▲ 159.96% |
|---|---|
| Total Calls | 393,925▼ 51.52% |
| Total Puts | 1,391,000▼ 11.37% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 47.35%▲ 15.60% |
|---|---|
| Total Invested | $678.69M▲ 146.57% |
| Investors Holding | 151▲ 35.00% |
ESG Score
No data
About BioAge Labs, Inc.
62 employees
CEO: Dr. Kristen Fortney Ph.D. BioAge Labs, Inc. is a clinical-stage biopharmaceutical company that develops therapeutic product candidates for metabolic diseases. The company's technology platform and differentiated human datasets allows users to identify targets bas...
Relevant Senate Committees
This powerful committee controls taxation, trade, and entitlement spending. Its decisions on corporate tax policy and Medicare/Medicaid reimbursement rates directly impact the profitability, market access, and overall valuation of biopharmaceutical companies.
This committee directly allocates federal discretionary spending. Its subcommittees determine precise funding for health-related agencies (e.g., NIH) and public health programs, directly influencing research and development opportunities and the market for future therapies.
This committee directly regulates the FDA (drug approval process) and the NIH (research funding), both of which are absolutely critical to the development, approval, and funding of a biopharmaceutical company's products.
BioAge Labs is developing a treatment for obesity in older adults. This committee's investigations into drug pricing and long-term care quality for older Americans directly impact market sentiment and potential revenue for products targeting this demographic.